Back to top
more

ICU Medical (ICUI)

(Delayed Data from NSDQ)

$96.72 USD

96.72
171,083

-1.04 (-1.06%)

Updated Apr 24, 2024 04:00 PM ET

After-Market: $96.57 -0.15 (-0.16%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (150 out of 251)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for ICUI

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for ICU Medical, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 255 213 567 411 293
Receivables 162 222 106 124 202
Notes Receivable 0 0 0 0 0
Inventories 709 696 290 315 338
Other Current Assets 96 104 66 71 50
Total Current Assets 1,221 1,235 1,030 921 882
Net Property & Equipment 613 636 468 467 456
Investments & Advances 0 1 5 13 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 37 31 43 31 28
Intangibles 2,343 2,432 232 230 243
Deposits & Other Assets 94 105 64 55 49
Total Assets 4,378 4,516 1,881 1,764 1,692
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 150 216 81 72 129
Current Portion Long-Term Debt 51 30 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 268 243 118 97 118
Income Taxes Payable 8 6 1 0 2
Other Current Liabilities 5 0 0 26 0
Total Current Liabilities 482 495 201 195 248
Mortgages 0 0 0 0 0
Deferred Taxes/Income 56 126 1 2 2
Convertible Debt 0 0 0 0 0
Long-Term Debt 1,578 1,624 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 140 181 62 64 65
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 2,255 2,426 265 261 315
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 2 2 2 2 2
Capital Surplus 1,366 1,331 721 693 669
Retained Earnings 808 838 912 809 722
Other Equity -53 -81 -19 -2 -15
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 2,123 2,090 1,616 1,502 1,377
Total Liabilities & Shareholder's Equity 4,378 4,516 1,881 1,764 1,692
Total Common Equity 2,123 2,090 1,616 1,502 1,377
Shares Outstanding 24.10 23.90 21.20 20.90 20.60
Book Value Per Share 88.11 87.44 76.23 71.88 66.86

Fiscal Year End for ICU Medical, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 255 199 198 224
Receivables NA 162 162 162 139
Notes Receivable NA 0 0 0 0
Inventories NA 709 760 775 748
Other Current Assets NA 96 99 110 101
Total Current Assets NA 1,221 1,219 1,245 1,213
Net Property & Equipment NA 613 609 617 624
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 37 31 31 31
Intangibles NA 2,343 2,336 2,394 2,420
Deposits & Other Assets NA 94 108 100 102
Total Assets NA 4,378 4,377 4,463 4,471
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 150 149 167 186
Current Portion Long-Term Debt NA 51 46 40 35
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 268 251 255 235
Income Taxes Payable NA 8 11 20 6
Other Current Liabilities NA 5 6 2 0
Total Current Liabilities NA 482 464 484 462
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 56 78 90 115
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 1,578 1,589 1,601 1,612
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 147 174 181
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 2,255 2,279 2,348 2,370
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 2 2 2 2
Capital Surplus NA 1,366 1,356 1,345 1,340
Retained Earnings NA 808 825 818 828
Other Equity NA -53 -85 -49 -62
Treasury Stock NA 0 1 2 8
Total Shareholder's Equity NA 2,123 2,098 2,115 2,100
Total Liabilities & Shareholder's Equity NA 4,378 4,377 4,463 4,471
Total Common Equity 0 2,123 2,098 2,115 2,100
Shares Outstanding 24.30 24.10 24.10 24.00 24.00
Book Value Per Share 0.00 88.11 87.07 88.12 87.52